skip to main content

Valproate teratogenic risk — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyAdverse Drug Reactions and Drug SafetyValproate teratogenic riskGPhC CRA

A woman taking valproate says she may be pregnant and asks whether to stop treatment immediately. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Arrange urgent specialist advice and discuss pregnancy safety without abrupt unsupervised stopping

Valproate is highly teratogenic but abrupt cessation may risk seizures. The best answer addresses the key safety, legal or pharmaceutical care issue in the vignette. The other options would either delay appropriate care, create a new risk, or fail to resolve the issue. This is consistent with the cited UK reference for safe pharmacy practice.

Reference: BNF; MHRA; GPhC Standards